Dihydroartemisinin inhibits angiogenesis induced by multiple myeloma RPMI8226 cells under hypoxic conditions via downregulation of vascular endothelial growth factor expression and suppression of vascular endothelial growth factor secretion.
第一作者:
Xiu-Hua,Wu
第一单位:
Institute of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Zhejiang University, Hangzhou, PRC.
作者:
主题词
尿囊素(Allantoin);血管生成抑制剂(Angiogenesis Inhibitors);动物(Animals);青蒿素类(Artemisinins);印迹法, 蛋白质(Blotting, Western);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);鸡胚(Chick Embryo);培养基, 条件性(Culture Media, Conditioned);减量调节(Down-Regulation);酶激活(Enzyme Activation);酶联免疫吸附测定(Enzyme-Linked Immunosorbent Assay);细胞外信号调节MAP激酶类(Extracellular Signal-Regulated MAP Kinases);流式细胞术(Flow Cytometry);人类(Humans);膜(Membranes);多发性骨髓瘤(Multiple Myeloma);RNA, 信使(RNA, Messenger);逆转录聚合酶链反应(Reverse Transcriptase Polymerase Chain Reaction);倍半萜类(Sesquiterpenes);信号传导(Signal Transduction);四唑鎓盐类(Tetrazolium Salts);噻唑类(Thiazoles);血管内皮生长因子A(Vascular Endothelial Growth Factor A)
DOI
10.1097/01.cad.0000224443.85834.32
PMID
16926633
发布时间
2021-09-15
- 浏览22

Anti-cancer drugs
839-48页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文